Flu vaccine strains selected
FDA's Vaccines & Related Biological Products Advisory Committee recommends Feb. 17 that influenza vaccines for the 2006-2007 season include an A/New Caledonia/20/99 (H1N1)-like virus (A/Wisconsin/67/2005 and A/Hiroshima/52/2005 strains); an A/Wisconsin/67/2005 (H3N2)-like virus; and a B/Malaysia/2506/2004-like virus (B/Malaysia/2506/2004 and B/Ohio/1/2005 strains). CDC's Advisory Committee on Immunization Practices advised Feb. 23 that routine flu vaccination include all children ages six months to five years...
You may also be interested in...
China’s first domestically-developed recombinant protein vaccine for COVID-19 moves forward in late-stage trials in two countries.
Splitting Colfax into separate fabrication technology and specialty medical technology businesses will help both sides of the business grow, CEO Matthew Trerotola said recently.
Given its ever-growing role as a critical component of the global biopharma industry, you can’t afford not to be up to speed on Asia. This selection of recent insights from our experienced on-the-ground team will help.